Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: A cross-sectional survey

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Nguyen, Christelle ^a,d   Ranque, Brigitte ^b   Baubet, Thierry ^c   Bérezné, Alice ^a   Mestre Stanislas, Caroline ^a   Rannou, Francois ^d   Papelard, Agathe ^d   Morell Dubois, Sandrine ^e   Revel, Michel ^d   Moro, Marie Rose ^d   Guillevin, Loic ^a   Poiraudeau, Serge ^d   Mouthon, Luc ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c AVICENNE HOSPITAL   (France)

^d Service de Médecine Physique et Réadaptation Hôpital Cochin Institut Fédé Ratif de Recherche sur le Handicap ^*  (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AESTHETIC IMPAIRMENT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLOBAL DISABILITY; HAND DISABILITY; HEALTH STATUS; HOSPITAL ANXIETY DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; QUALITY OF LIFE; SELF REPORT; SEX DIFFERENCE; SHORT FORM 36; SYMPTOM; SYSTEMIC SCLEROSIS; ANXIETY; ANXIETY DISORDERS; DEPRESSIVE DISORDER; HEALTH SURVEY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; SCLERODERMA, SYSTEMIC; STATISTICS AND NUMERICAL DATA;

AGED; ANXIETY; ANXIETY DISORDERS; CROSS-SECTIONAL STUDIES; DEPRESSION; DEPRESSIVE DISORDER; DISABILITY EVALUATION; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SCLERODERMA, SYSTEMIC; SURVEYS AND QUESTIONNAIRES;

EID: 84896506258     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090484     Document Type: Article

References (64)

1. Tamby MC, Chanseaud Y, Guillevin L, Mouthon L (2003) New insights into the pathogenesis of systemic sclerosis. Autoimmun Rev 2: 152-157. (Pubitemid 37443852)
2. Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, et al. (2005) Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 52: 3792-3800. (Pubitemid 41798217)
3. Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, et al. (2003) Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 62: 1088- 1093. (Pubitemid 37323574)
4. Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43: 2437-2444.
5. Poole JL, Steen VD (1991) The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 4: 27-31.
6. Mura G, Bhat KM, Pisano A, Licci G, Carta M (2012) Psychiatric symptoms and quality of life in systemic sclerosis. Clin Pract Epidemiol Ment Health 8: 30- 35.
7. Angelopoulos NV, Drosos AA, Moutsopoulos HM (2001) Psychiatric symptoms associated with scleroderma. Psychother Psychosom 70: 145-150. (Pubitemid 32429716)
8. Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, Boling C, Reed J, et al. (2002) The impact of pain and symptoms of depression in scleroderma. Pain 95: 267-275. (Pubitemid 34142650)
9. Beretta L, Astori S, Ferrario E, Caronni M, Raimondi M, et al. (2006) [Determinants of depression in 111 Italian patients with systemic sclerosis]. Reumatismo 58: 219-225. (Pubitemid 44450249)
10. Haythornthwaite JA, Heinberg LJ, McGuire L (2003) Psychologic factors in scleroderma. Rheum Dis Clin North Am 29: 427-439. (Pubitemid 36765129)
11. Hyphantis TN, Tsifetaki N, Pappa C, Voulgari PV, Siafaka V, et al. (2007) Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. J Psychosom Res 62: 47-56. (Pubitemid 44937348)
12. Legendre C, Allanore Y, Ferrand I, Kahan A (2005) Evaluation of depression and anxiety in patients with systemic sclerosis. Joint Bone Spine 72: 408-411. (Pubitemid 41415829)
13. Matsuura E, Ohta A, Kanegae F, Haruda Y, Ushiyama O, et al. (2003) Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol 30: 1782-1787. (Pubitemid 36962455)
14. Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, et al. (2005) Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 32: 51-57. (Pubitemid 40092591)
15. Richards HL, Herrick AL, Griffin K, Gwilliam PD, Fortune DG (2004) Psychological adjustment to systemic sclerosis: exploring the association of disease factors, functional ability, body related attitudes and fear of negative evaluation. Psychol Health Med 9: 29-39. (Pubitemid 38155620)
16. Roca RP, Wigley FM, White B (1996) Depressive symptoms associated with scleroderma. Arthritis Rheum 39: 1035-1040. (Pubitemid 26182074)
17. Straszecka J, Kucharz EJ, Jonderko G, Kotulska A, Bednarczyk-Kaluzny M, et al. (1996) Depression and anxiety in patients with systemic sclerosis. Clin Rheumatol 15: 621.
18. Hudson M, Thombs BD, Steele R, Watterson R, Taillefer S, et al. (2008) Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. Arthritis Rheum 59: 279-284. (Pubitemid 351272966)
19. Thombs BD, Taillefer SS, Hudson M, Baron M (2007) Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum 57: 1089-1097. (Pubitemid 47237338)
20. Mozzetta A, Antinone V, Alfani S, Neri P, Foglio Bonda PG, et al. (2008) Mental health in patients with systemic sclerosis: a controlled investigation. J Eur Acad Dermatol Venereol 22: 336-340. (Pubitemid 351247424)
21. Ostojic P, Zivojinovic S, Reza T, Damjanov N (2010) Symptoms of depression and anxiety in Serbian patients with systemic sclerosis: impact of disease severity and socioeconomic factors. Mod Rheumatol.
22. Nguyen C, Bérezné A, Baubet T, Mestre-Stanislas C, Rannou F, et al. (2011) Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS One 6: e17551.
23. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23: 581-590.
24. LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28: 1573-1576.
25. Evans C, McCarthy M (1985) Prognostic uncertainty in terminal care: can the Karnofsky index help? Lancet 1: 1204-1206. (Pubitemid 15083681)
26. Bérezné A, Seror R, Morell-Dubois S, de Menthon M, Foïs E, et al. (2011) Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res (Hoboken) 63: 277- 285.
27. Mestre-Stanislas C, Poiraudeau S, Bérezné A, Rannou F, Pagnoux C, et al. (2010) Differences in patients with systemic sclerosis recruited from associations and tertiary care settings. Presse Med 39: e205-209.
28. Mouthon L, Rannou F, Bérezné A, Pagnoux C, Arene JP, et al. (2007) Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scale. Ann Rheum Dis 66: 1651- 1655. (Pubitemid 350205456)
29. Mouthon L, Rannou F, Bérezné A, Pagnoux C, Guilpain P, et al. (2008) Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey. Arthritis Rheum 59: 968-973. (Pubitemid 351990993)
30. Nguyen C, Mouthon L, Mestre-Stanislas C, Rannou F, Bérezné A, et al. (2010) Sensitivity to Change in Systemic Sclerosis of the McMaster-Toronto Arthritis Patient Preference Disability Questionnaire (MACTAR): Shift in Patient Priorities Over Time. J Rheumatol 37: 359-364.
31. Nguyen C, Poiraudeau S, Mestre-Stanislas C, Rannou F, Bérezné A, et al. (2010) Employment status and socio-economic burden in systemic sclerosis: a cross-sectional survey. Rheumatology (Oxford) 49: 982-989.
32. Rannou F, Poiraudeau S, Bérezné A, Baubet T, Le-Guern V, et al. (2007) Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. Arthritis Rheum 57: 94-102.
33. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473-483.
34. Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, et al. (2002) Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum 46: 2410-2420.
35. Pope J (2011) Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patientrated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS). Arthritis Care Res (Hoboken) 63 Suppl 11: S98-111.
36. Johnson SR, Hawker GA, Davis AM (2005) The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties. Arthritis Rheum 53: 256-262. (Pubitemid 40530167)
37. Tugwell P, Bombardier C, Buchanan WW, Goldsmith CH, Grace E, et al. (1987) The MACTAR Patient Preference Disability Questionnaire-an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol 14: 446-451. (Pubitemid 17121196)
38. Duruoz MT, Poiraudeau S, Fermanian J, Menkes CJ, Amor B, et al. (1996) Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 23: 1167-1172.
39. Hesselstrand R, Nilsson JA, Sandqvist G (2013) Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis. Scand J Rheumatol 42: 317-324.
40. Poole JL (2011) Measures of hand function: Arthritis Hand Function Test (AHFT), Australian Canadian Osteoarthritis Hand Index (AUSCAN), Cochin Hand Function Scale, Functional Index for Hand Osteoarthritis (FIHOA), Grip Ability Test (GAT), Jebsen Hand Function Test (JHFT), and Michigan Hand Outcomes Questionnaire (MHQ). Arthritis Care Res (Hoboken) 63 Suppl 11: S189-199.
41. Maddali Bongi S, Del Rosso A, Miniati I, Galluccio F, Landi G, et al. (2012) The Italian version of the Mouth Handicap in Systemic Sclerosis scale (MHISS) is valid, reliable and useful in assessing oral health-related quality of life (OHRQoL) in systemic sclerosis (SSc) patients. Rheumatol Int 32: 2785-2790.
42. Schouffoer AA, Strijbos E, Schuerwegh AJ, Mouthon L, Vliet Vlieland TP (2013) Translation, cross-cultural adaptation, and validation of the Mouth Handicap in Systemic Sclerosis questionnaire (MHISS) into the Dutch language. Clin Rheumatol 32: 1649-1655.
43. Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52: 69-77. (Pubitemid 34192886)
44. Honarmand K, Feinstein A (2009) Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler 15: 1518- 1524.
45. Baubet T, Ranque B, Taieb O, Bérezné A, Bricou O, et al. (2011) Mood and anxiety disorders in systemic sclerosis patients. Presse Med 40: e111-119.
46. Danieli E, Airo P, Bettoni L, Cinquini M, Antonioli CM, et al. (2005) Healthrelated quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 24: 48-54. (Pubitemid 40214800)
47. Ritchie K, Artero S, Beluche I, Ancelin ML, Mann A, et al. (2004) Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatry 184: 147-152. (Pubitemid 38186856)
48. Lepine JP, Gasquet I, Kovess V, Arbabzadeh-Bouchez S, Negre-Pages L, et al. (2005) [Prevalence and comorbidity of psychiatric disorders in the French general population]. Encephale 31: 182-194. (Pubitemid 40675702)
49. Jewett LR, Razykov I, Hudson M, Baron M, Thombs BD, et al. (2013) Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis. Rheumatology (Oxford) 52: 669-675.
50. Bouvard M, Cottraux J (1996) Protocoles et échelles d'évaluation en psychiatrie et en psychologie; Masson, editor. Paris: Masson.
51. Lepine JP, Pariente P, Boulenger JP, Hardy P, Zarifian E, et al. (1989) Anxiety disorders in a French general psychiatric outpatient sample. Comparison between DSM-III and DSM-IIIR criteria. Soc Psychiatry Psychiatr Epidemiol 24: 301-308. (Pubitemid 20043154)
52. Poole JL (1994) Grasp pattern variations seen in the scleroderma hand. Am J Occup Ther 48: 46-54.
53. Sandqvist G, Hesselstrand R, Eberhardt K (2009) A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis. Scand J Rheumatol: 1-7.
54. Heinberg LJ, Kudel I, White B, Kwan A, Medley K, et al. (2007) Assessing body image in patients with systemic sclerosis (scleroderma): validation of the adapted Satisfaction with Appearance Scale. Body Image 4: 79-86.
55. Richards HL, Herrick AL, Griffin K, Gwilliam PD, Loukes J, et al. (2003) Systemic sclerosis: patients' perceptions of their condition. Arthritis Rheum 49: 689-696. (Pubitemid 37296475)
56. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, et al. (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363: 1665-1672. (Pubitemid 38670323)
57. Akpek G, Zahurak ML, Piantadosi S, Margolis J, Doherty J, et al. (2001) Development of a prognostic model for grading chronic graft-versus-host disease. Blood 97: 1219-1226. (Pubitemid 32183742)
58. Imaizumi T, Chiba M, Honma T, Niwa J (2003) Detection of hemosiderin deposition by T2*-weighted MRI after subarachnoid hemorrhage. Stroke 34: 1693-1698. (Pubitemid 36842629)
59. Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, et al. (2005) Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 24: 3-10. (Pubitemid 40214792)
60. Cosco TD, Doyle F, Ward M, McGee H (2012) Latent structure of the Hospital Anxiety And Depression Scale: a 10-year systematic review. J Psychosom Res 72: 180-184.
61. Straat JH, van der Ark LA, Sijtsma K (2013) Methodological artifacts in dimensionality assessment of the hospital anxiety and depression scale (HADS). J Psychosom Res 74: 116-121.
62. Babyak MA (2004) What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 66: 411- 421. (Pubitemid 38668414)
63. Rouchell A, Pounds R, Tierney J (1996) Depression. Textbook of consultationliaison psychiatry. Washington: American Psychiatric Press. 311-345 p.
64. Lamberg L (1996) Treating depression in medical conditions may improve quality of life. Jama 276: 857-858. (Pubitemid 26301592)